New ray medic International Holdings Limited (New Ray Medic) announced that for the six months ended June 30, 2024, the group's net loss will not exceed HK$5 million, a significant decrease from HK$13.4 million in the same period in 2023. This improvement is mainly attributed to the significant reduction in exchange losses and impairment losses on receivables, as well as a reduction in marketing service fees and shipping expenses. The company emphasizes that these data are based on a preliminary review of the unaudited management accounts and have not been reviewed or audited by auditors. The final data will be disclosed on August 28, 2024. The company reminds shareholders and potential investors to exercise caution when trading in the company's securities.

New ray medic International Holdings Limited (New Ray Medic) announced that for the six months ended June 30, 2024, the group's net loss will not exceed HK$5 million, a significant decrease from HK$13.4 million in the same period in 2023. This improvement is mainly attributed to the significant reduction in exchange losses and impairment losses on receivables, as well as a reduction in marketing service fees and shipping expenses. The company emphasizes that these data are based on a preliminary review of the unaudited management accounts and have not been reviewed or audited by auditors. The final data will be disclosed on August 28, 2024. The company reminds shareholders and potential investors to exercise caution when trading in the company's securities.